The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost

Cancer Invest. 2012 Nov;30(9):637-41. doi: 10.3109/07357907.2012.726387. Epub 2012 Sep 28.

Abstract

Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients.

Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed.

Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades.

Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Disease-Free Survival
  • Female
  • Humans
  • Life Expectancy*
  • Male
  • Melanoma / diagnosis
  • Melanoma / mortality*
  • Melanoma / secondary*
  • Middle Aged
  • Neoplasm Metastasis*